Angelica LaVito, CNBC.com’s Posts

Philip Morris International beat second-quarter earnings and revenue estimates and hiked its full-year forecast Thursday as its new tobacco products gained momentum.

Johnson & Johnson vowed to defend itself against lawsuits alleging the company fueled the opioid crisis and that its namesake talc-based baby powder caused ovarian cancer and mesothelioma.

Kevin Burns, CEO of Juul Labs ⁠— the maker of the bestselling e-cigarette in the U.S. and center of federal regulators’ crackdown into what they’re calling a teen vaping “epidemic” ⁠— has a message for parents whose children are addicted to his company’s products: “I’m sorry.”

Campaign for Tobacco-Free Kids slammed Juul’s “fake apology” on Monday, saying it’s “a blatant attempt to deflect attention from the company’s wrongdoing” in “creating the youth e-cigarette epidemic.”

CVS will bring its health-focused stores to Boston, Dallas-Fort Worth, North Carolina and Ohio, among other markets, early next year, the company announced.

U.S. lawmakers weighed reforming pot laws in what advocates called a “historic” hearing Wednesday, with numerous members of Congress saying they wanted to loosen federal laws, even legalize marijuana.

The Trump administration has withdrawn its proposal to eliminate rebates from government drug plans, a key component of the president’s blueprint to lower prescription drug prices, a White House spokesman confirmed.

Sen. Elizabeth Warren, D-Mass., on Tuesday called on Scott Gottlieb, the former head of the Food and Drug Administration, to resign from Pfizer’s board of directors, saying the appointment two months after leaving the agency “smacks of corruption.”

Walgreens Boots Alliance on Thursday beat fiscal third-quarter earnings estimates as higher prescription drug sales helped the company regain its footing after CEO Stefano Pessina dubbed last quarter “the most difficult” since the company was formed.

Peloton, best known for its exercise cycles, announced Wednesday it has filed with securities regulators for an initial public offering.

Johnson & Johnson outlined plans to grow its pharmaceutical business on Wednesday.

J&J CEO Alex Gorsky told CNBC that the company needs to focus on new innovations.

Walmart plans to increase the minimum age to buy tobacco products to 21 starting July 1, joining a growing list of retailers under pressure from federal regulators to curb sales to minors and boosting their age restrictions as a result.

U.S. health officials confirmed another 78 cases of measles last week, urging people to vaccinate as they battle the worst year for the disease in 25 years.

Walgreens is increasing the age to buy tobacco at its drugstores to 21 later this year as the retailer faces possible sanctions from the Food and Drug Administration for allegedly selling to minors.

Johnson & Johnson’s mounting legal costs ate into its first-quarter profits, which dropped 14% as it fights thousands of lawsuits over its talc baby powder and shelled out almost $400 million to settle 25,000 cases over its blockbuster blood thinner Xarelto.